Tyrosine was a particularly, and significantly, stronger predictor of incident diabetes in South Asians than in Europeans
Adjusting diet could help optimise metabolic control and prevent complications of type II diabetes
Vancocin capsules had annual US sales of $ 164.2 million
The drug is the first FDA-approved medication to treat this condition
The FDA’s review of TissuGlu included data from a clinical study of 130 participants undergoing elective abdominoplasty
Cosentyx approval is based on phase III programme demonstrating high, sustained efficacy in the skin clearance of moderate-to-severe plaque psoriasis
Dr T Rajkumar, Director and Scientific Director, Cancer Institute (WIA), Adyar elaborates about the ongoing research work at the institute as well as his perspective...
CLEAR is the second head-to-head study for Cosentyx following the phase III Fixture study that showed Cosentyx was superior to Enbrel (etanercept)
A 35 per cent increased risk of type II diabetes was found in those with group B
The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities, says this year’s...
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
(ODAC) did not recommend the investigational compound LBH589, a pan-deacetylase inhibitor, for patients with previously treated multiple myeloma when used in combination with bortezomib ...
The FDA Medicare analysis is based on patient data from elderly patients enrolled in Medicare
Patients with psoriatic arthritis were 36 per cent more likely than the comparison group to suffer a heart attack
DIBER has transferred the technology of the drug, which is being showcased at the ongoing Arogya Expo 2014
The live, oral, ready-to-use tetravalent rotavirus vaccine candidate is designed to protect young children from severe diarrhoea
To enroll patients in the imminent HEP002 Phase IIb/ III clinical trial
Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection
Akynzeo treats nausea and vomiting in patients undergoing cancer chemotherapy